DNA polymerase mu: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{No image}} | {{No image}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 08:26, 17 March 2025
DNA polymerase mu (Pol μ) is a unique DNA polymerase that is involved in the process of non-homologous end joining (NHEJ), a mechanism used by cells to repair double-strand breaks in DNA. Unlike most DNA polymerases, Pol μ possesses the ability to perform template-independent DNA synthesis, making it crucial for the repair of breaks that have incompatible or damaged ends. This enzyme is a member of the X family of DNA polymerases, which also includes Pol β, Pol λ, and TdT.
Function[edit]
Pol μ's primary role is in the repair of double-strand breaks in DNA through NHEJ. This pathway is essential for maintaining genomic stability, especially in the immune system during V(D)J recombination, a process that generates the diversity of antibodies. Unlike homologous recombination, NHEJ does not require a homologous template, making Pol μ's template-independent activity particularly valuable. Pol μ can add nucleotides at the break site, facilitating the bridging and eventual ligation of the DNA ends.
Structure[edit]
The structure of Pol μ shares similarities with other members of the X family of DNA polymerases, including a BRCT domain that is thought to be involved in protein-protein interactions necessary for its function in DNA repair. However, Pol μ also exhibits unique structural features that enable its template-independent synthesis capabilities, including a highly flexible active site.
Clinical Significance[edit]
Mutations in the gene encoding Pol μ have been associated with an increased susceptibility to various cancers, highlighting the enzyme's role in preventing genomic instability. Additionally, due to its role in V(D)J recombination, alterations in Pol μ activity can impact the immune system's ability to generate antibody diversity, potentially leading to immunodeficiency disorders.
Research[edit]
Research on Pol μ is ongoing, with studies aimed at elucidating its precise mechanisms of action, its interactions with other proteins involved in DNA repair, and its potential as a target for cancer therapy. Understanding the detailed function of Pol μ could lead to novel approaches to enhance DNA repair in diseases characterized by genomic instability.
See Also[edit]
References[edit]
<references />
| Y-STR Name |
| Haplotype |
